Inside This Issue - News
CACDS: No lack of challenges on horizon
April 6th, 2009
by Alasdair McKichan
TORONTO – The 360 delegates from Canada’s chain drug industry, its suppliers and academia who attended the Canadian Association of Chain Drug Stores (CACDS) annual conference here discussed a short-term future much brighter than that faced by other sectors of Canadian retailing.
Still, Canadian pharmacies and the professionals who own or staff them have no shortage of challenges this year and over the next few years, CACDS chairman and Katz Group Canada executive vice president Russell Cohen told attendees.
Outlining key issues being tackled by CACDS, Cohen said that an expanded role for pharmacy is gaining acceptance but that much remains to be done to educate diverse stakeholders, including governments and patients. Given the tight economy, there was a sharp focus on generic drug pricing, professional allowances and compensation for pharmacy services.
More important, perhaps, is the work going on with industry partners to develop a “Blueprint for Pharmacy,” which would include a model for compensation that is designed to be fair to the profession, payers and patients. Meanwhile, the implementation of e-health is a positive development but requires a great deal of work and dedication from all concerned, Cohen added.
In the front end of the store, CACDS is helping members deal with new environmental concerns and public health issues, including those recently arising from cough/cold remedies and health and beauty products containing siloxanes.
Nadine Saby, CACDS’ president and chief executive officer, assured delegates that she and her colleagues know the important role that the association is playing at this critical time.